Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychosocial outcomes with once-daily tadalafil versus as-needed PDE5 inhibitor therapy in men with erectile dysfunction
2008-001055-21Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tadalafil and sildenafil in erectile dysfunction (ED) (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Change from baseline to endpoint in PAIRS Sexual Self-Confidence domain. Started May 2008; status: completed.
02
Drugs
tadalafilsildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2008-001055-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001055-21.